Wright Consulting provides management and advice to drive commercial development of innovative technology in the biomedical/biotechnology arena and has expertise and experience in:• Business planning• Start up company formation• Leadership and management (including executive and non-exec director roles and interim senior management positions )• IP strategy and patent portfolio management • Deal negotiation • Collaboration and project management• Technology scouting and competitor monitoringClients to date include independent inventors, early stage companies, investors, top universities and research institutes and funding bodies including research councils and charities.

Evgen is an AIM-listed company focused on the clinical development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. Its core technology is Sulforadex®, a unique, patented stabilisation method that enables sulforaphane to be delivered as a stable, solid, active ingredient in an oral pharmaceutical product. The company is also researching a number of synthetic, stabilised novel analogues of sulforaphane to advance this new class of pharmaceuticals.

Vecotech is the flagship spin-out company from the renowned London School of Hygiene & Tropical Medicine, established to capitalise upon the expertise and specific inventions and discoveries of its scientists in novel methods for the surveillance and control of medically important insects.

Ostara specialises in developing products to improve success rates of artificial reproduction.

Aura Biosciences, Inc. (www.aurabiosciences.com) is applying nanotechnology to fight cancer in using both chemotherapeutics and the emerging field of RNAi. Aura’s NanoSmart system addresses drug delivery by encapsulating therapies within protein nanoparticles engineered for precise targeting, immune system evasion and efficient cellular uptake. The company has in-licensed and combined technologies from leading European and US universities and research institutions.

Medical Research Council Technology (MRCT) is an affiliate of the MRC and acts as its sole agent in all matters of protection and development of intellectual property arising from the Council’s research Institutes and Units throughout the UK and overseas. MRCT is a company limited by guarantee, is a not-for-profit organisation and has charitable status.